Description
5-Amino-1-methylquinolinium (commonly abbreviated 5-Amino-1MQ) is a small-molecule quinolinium salt recognized in the literature as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that catalyzes the N-methylation of nicotinamide using S-adenosyl methionine as the methyl donor. Its core structure is a bicyclic aromatic quinoline ring system bearing an amino substituent at the 5-position and a quaternary nitrogen at the 1-position, conferring the cationic character characteristic of the quinolinium class.
NNMT occupies a central node in NAD⁺ metabolism and one-carbon transfer pathways, and its dysregulation has been documented across a range of biological contexts, including stromal and fibroblast cell populations within complex tissue microenvironments [1]. Researchers employ 5-Amino-1MQ as a chemical probe to interrogate how NNMT activity shapes downstream metabolic and epigenetic states, making it a useful tool compound for dissecting the enzyme's contributions to cellular signaling.
Preclinical investigations have applied 5-Amino-1MQ across multiple in vitro model systems to examine how NNMT inhibition influences cell proliferation, apoptotic signaling, and oncogenic protein expression. Work in cervical cancer cell lines, for example, identified concentration-dependent changes in phospho-Akt and Sirtuin-1 protein levels following exposure to the compound, alongside morphological indicators of apoptosis [2]. Separately, studies in urothelial bladder cancer models have used the compound to probe how NNMT activity in cancer-associated fibroblasts regulates macrophage recruitment and tumor microenvironment composition [1].
Together, these research applications position 5-Amino-1MQ as a valuable chemical tool for laboratories investigating NNMT biology, nicotinamide metabolism, tumor microenvironment dynamics, and the broader interplay between one-carbon metabolism and cellular epigenetics.
References
[1] NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for Immunotherapy of Cancer, 2024. https://pubmed.ncbi.nlm.nih.gov/39067875/
[2] Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells. Journal of Obstetrics and Gynaecology, 2021. https://pubmed.ncbi.nlm.nih.gov/33645410/
